Mutations in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness

Saskia B Wortmann,Frédéric M Vaz,Thatjana Gardeitchik,Lisenka E L M Vissers,G Herma Renkema,Janneke H M Schuurs-Hoeijmakers,Wim Kulik,Martin Lammens,Christin Christin,Leo A J Kluijtmans,Richard J Rodenburg,Leo G J Nijtmans,Anne Grünewald,Christine Klein,Joachim M Gerhold,Tamas Kozicz,Peter M van Hasselt,Magdalena Harakalova,Wigard Kloosterman,Ivo Barić,Ewa Pronicka,Sema Kalkan Ucar,Karin Naess,Kapil K Singhal,Zita Krumina,Christian Gilissen,Hans van Bokhoven,Joris A Veltman,Jan A M Smeitink,Dirk J Lefeber,Johannes N Spelbrink,Ron A Wevers,Eva Morava,Arjan P M de Brouwer
DOI: https://doi.org/10.1038/ng.2325
IF: 30.8
2012-06-10
Nature Genetics
Abstract:Ron Wevers, Saskia Wortmann and colleagues show that mutations in SERAC1 cause a recessive syndrome characterized by deafness, encephalopathy, progressive spasticity and dystonia. Their findings suggest a role for SERAC1 in phosphatidylglycerol remodeling and intracellular cholesterol trafficking.
genetics & heredity
What problem does this paper attempt to address?